Products

CAT # Product Name Description
CPD113103 1-((1S,2S)-2-aminocyclohexyl)-3-(3,5-bis(triflu...
CPDM400265 2-(2-Chloro-6-(1,3-dioxolan-2-yl)-5-fluoro-3-me...
CPDP803687 1-(6-(4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-m...
CPDM400057 Methyl 4-iodo-2-methyl-3-nitrobenzoate
CPDM400457 3-bromo-5-methylpyrazin-2-amine
CPDM400368 1-(oxetan-3-yl)piperazine 2,2,2-trifluoroacetate
CPDP803701 (S)-2-chloro-4-(6-(hydroxymethyl)-6-methyl-4-ox...
CPDM400454 4-bromo-N-ethyl-6,7-dihydro-6-methyl-7-oxo-1H-P...
CPD109670 28-Noroleana-1,9(11)-diene-2-carbonitrile, 17-a...
CPD107369 6′-bromospiro[cyclopropane-1,1'-inden]-3&...
CPD107368 5-methylspiro[cyclopropane-1,1-inden]-3(2H)-one
CPD107367 7-methylspiro[cyclopropane-1,1-inden]-3(2H)-one
CPD107366 6-methylspiro[cyclopropane-1,1-inden]-3(2H)-one
CPD107365 Spiro[cyclopropane-1,1-[1H]inden]-3(2H)-one
CPD107231 TNF-α-IN-2; TNFα-IN-42 TNF - α - IN-2 is an effective and orally active tumor necrosis factor alpha (TNF α) inhibitor.
CPD107230 PI3Kδ-IN-8 PI3K δ - IN-8 is an effective, selective, and orally active inhibitor of PI3K δ.
CPD106711 (1R,2S,3R,4R)-2,3-DIHYDROXY-4-(HYDROXYMETHYL)-1...
CPD106710 ((3aR,4R,6R,6aS)-6-amino-2,2-dimethyltetrahydro...
CPD106634 UJN49930; UGT8 Inhibitor 19; CGT Inhibitor 19; ... UGT8-IN-1 is an orally active inhibitor of ceramide galactosyltransferase (UGT8) that can cross the blood-brain barrier.
CPD106633 FNDR-20123 FNDR-20123 is an effective, safe, and pioneering anti malaria HDAC inhibitor.
CPD3638 Adagrasib; MRTX849 Adagrasib (MRTX849) is a potent, orally available, mutation-selective covalent inhibitor of KRAS G12C.
CPD109136 TPX-0046; Enbezotinib Enbezotinib is a tyrosine kinase inhibitor, RET autophosphorylation inhibitor, and antineoplastic agent.
ABT 888,Veliparib
CPDP803642 cis-tert-Butyl 3,4-diaminopyrrolidine-1-carboxy...
BAY-6672 BAY-6672 is a chemical probe that is an effective and selective human prostaglandin F (FP) receptor antagonist.
BAY-6672 hydrochloride BAY-6672 hydrochloride is a potent and selective human prostaglandin F (FP) receptor antagonist.
CPDP801866 Tuspetinib; HM43239 Tuspinib (HM43239) is a selective FLT3 inhibitor with oral activity.
CPD113409 SGR 1505; DCC-3116 SGR-1505 is an orally active MALT1 allosteric inhibitor.
CPDP802017 CB-Cyclam; M-200 CB Cyclam is a bifunctional chelating agent (BFC), which is a derivative of the macrocyclic ligand tetradecane main chain Cyclen.
CPDP801669 Zefamenib; Zefamenibum; BN-104 BN-104 (BNM-1192) is a selective meningeal protein inhibitor with oral activity and is also a Menin inhibitor.

Contact Us

Inquiry

Latest News

  • Top 7 Trends In Pharmaceutical Research In 2018

    Top 7 Trends In Pharmaceutical Research I...

      Being under ever-increasing pressure to compete in a challenging economic and technological environment, pharmaceutical and biotech companies must continually innovate in their R&D programmes to stay ahead ...

  • ARS-1620: A promising new inhibitor for KRAS-mutant cancers

    ARS-1620: A promising new inhibitor for K...

    According to a study published in Cell, researchers have developed a specific inhibitor for KRASG12C called ARS-1602 that induced tumor regression in mice. “This study provides in vivo evidence that mutant KRAS can be...

  • AstraZeneca receives regulatory boost for oncology drugs

    AstraZeneca receives regulatory boost for...

    AstraZeneca received a double boost for its oncology portfolio on Tuesday, after US and European regulators accepted regulatory submissions for its drugs, the first step towards winning approval for these medicines. ...

WhatsApp Online Chat !